Back
Corporate News
Suven Life Sciences allots 3.17 cr equity shares on conversion of warrants
06-Mar-2026, 12:04
Suven Life Sciences has allotted 3,17,68,764 equity shares of Re 1 each on conversion of warrants. Post allotment, the paid up equity share capital has increased to 2637,20,583 equity shares of Re 1 each.
Suven Life Sciences has allotted 3,17,68,764 equity shares of Re 1 each on conversion of warrants. Post allotment, the paid up equity share capital has increased to 2637,20,583 equity shares of Re 1 each.
Powered by Capital Market - Live News